Clinical and Translational Oncology

, Volume 16, Issue 3, pp 315–321 | Cite as

Microvesicle microRNA profiles and functional roles between chronic hepatitis B and hepatocellular carcinoma

  • H. Li
  • L. Sun
  • X. Chen
  • W. Xiong
  • D. Hu
  • S. JieEmail author
Research Article



Hepatocellular carcinoma (HCC) is an inflammation-related malignancy and chronic hepatitis B (CHB) predisposes to HCC. Microvesicles (MVs) transfer various bioactive molecules including microRNA (miRNA) between cells and exert biological functions. The purpose of this study was to detect CHB-MV and HCC-MV miRNAs and analyze the expression profiles and functional roles between CHB and HCC.


We examined MV miRNA profiles of CHB and HCC using miRNA microarrays. TargetScan, PicTar and miRanda were exerted to predict target genes regulating these differentially expressed miRNAs.


A total of 272 and 242 aberrant fluctuation miRNAs were identified in CHB-MVs and HCC-MVs, respectively. Among them, there were 53 miRNAs co-expressing both in CHB-MVs and HCC-MVs. These miRNAs affected cellular apoptosis, proliferation and molecular signaling pathways. Among them, 25 co-expressed MV miRNAs targeted 21 inflammatory factors and these miRNAs may be a tight linkage between CHB and HCC. Interestingly, there were 14 co-expressed MV miRNAs targeting 17 oncogenes and 7 miRNAs targeting 9 tumor suppressors in the study. In addition, MVs were enriched with maladjusted miRNAs regulating zinc finger proteins and chromosome open reading frame. Those MV miRNAs may play roles in CHB developing to HCC.


We demonstrated that CHB and HCC displayed aberrantly co-expressed MV miRNA profiles for the first time, which may have a link between CHB and HCC. Those MV miRNAs may serve as early biomarkers for HCC and may aid to promote CHB developing to HCC.


Microvesicle (MV) MicroRNA (miRNA) profiles Functional roles Chronic hepatitis B (CHB) Hepatocellular carcinoma (HCC) 



This work was supported by the National Nature Science Foundation of China (Grant 81170462).

Conflict of interest

The authors who have taken part in this study declared that they do not have anything to disclose the conflict of interest with this manuscript.


  1. 1.
    Block TM, Mehta AS, Fimmel CJ, Jordan R. Molecular viral oncology of hepatocellular carcinoma. Oncogene. 2003;22:5093–107.PubMedCrossRefGoogle Scholar
  2. 2.
    Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420:860–7.PubMedCentralPubMedCrossRefGoogle Scholar
  3. 3.
    Poehlmann A, Kuester D, Malfertheiner P, Guenther T, Roessner A. Inflammation and Barrett’s carcinogenesis. Pathol Res Pract. 2012;208:269–80.PubMedCrossRefGoogle Scholar
  4. 4.
    Liao R, Sun TW, Yi Y, Wu H, Li YW, Wang JX, et al. Expression of TREM-1 in hepatic stellate cells and prognostic value in hepatitis B-related hepatocellular carcinoma. Cancer Sci. 2012;103:984–92.PubMedCrossRefGoogle Scholar
  5. 5.
    Benameur T, Andriantsitohaina R, Martínez MC. Therapeutic potential of plasma membrane-derived microparticles. Pharmacol Rep. 2009;61:49–57.PubMedGoogle Scholar
  6. 6.
    Gyorgy B, Szabo TG, Pasztoi M, Pal Z, Misjak P, Aradi B, et al. Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles. Cell Mol Life Sci. 2011;68:2667–88.PubMedCentralPubMedCrossRefGoogle Scholar
  7. 7.
    Lee TH, D’Asti E, Magnus N, Al-Nedawi K, Meehan B, Rak J. Microvesicles as mediators of intercellular communication in cancer-the emerging science of cellular ‘debris’. Semin Immunopathol. 2011;33:455–67.PubMedCrossRefGoogle Scholar
  8. 8.
    Mathivanan S, Ji H, Simpson RJ. Exosomes: extracellular organelles important in intercellular communication. J Proteomics. 2010;73:1907–20.PubMedCrossRefGoogle Scholar
  9. 9.
    Simons M, Raposo G. Exosomes-vesicular carriers for intercellular communication. Curr Opin Cell Biol. 2009;21:575–81.PubMedCrossRefGoogle Scholar
  10. 10.
    Chai N, Chang HE, Nicolas E, Han Z, Jarnik M, Taylor J, et al. Properties of subviral particles of hepatitis B virus. J Virol. 2008;82:7812–7.PubMedCentralPubMedCrossRefGoogle Scholar
  11. 11.
    Dalli J, Norling LV, Renshaw D, Cooper D, Leung KY, Perretti M, et al. Annexin 1 mediates the rapid anti-inflammatory effects of neutrophil-derived microparticles. Blood. 2008;112:2512–9.PubMedCrossRefGoogle Scholar
  12. 12.
    Schetter AJ, Heegaard NH, Harris CC. Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways. Carcinogenesis. 2010;31:37–49.PubMedCrossRefGoogle Scholar
  13. 13.
    Gui J, Tian Y, Wen X, Zhang W, Zhang P, Gao J, et al. Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies. Clin Sci (Lond). 2011;120:183–93.CrossRefGoogle Scholar
  14. 14.
    Hunter MP, Ismail N, Zhang X, Aguda BD, Lee EJ, Yu L, et al. Detection of microRNA expression in human peripheral blood microvesicles. PLoS ONE. 2008;3:e3694.PubMedCentralPubMedCrossRefGoogle Scholar
  15. 15.
    Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, Castle J, et al. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature. 2005;433:769–73.PubMedCrossRefGoogle Scholar
  16. 16.
    Selbach M, Schwanhausser B, Thierfelder N, Fang Z, Khanin R, Rajewsky N, et al. Widespread changes in protein synthesis induced by microRNAs. Nature. 2008;455:58–63.PubMedCrossRefGoogle Scholar
  17. 17.
    Cordes KR, Srivastava D. MicroRNA regulation of cardiovascular development. Circ Res. 2009;104:724–32.PubMedCentralPubMedCrossRefGoogle Scholar
  18. 18.
    Takamizawa J, Konishi H, Yanagisawa K, Tomida S, Osada H, Endoh H, et al. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res. 2004;64:3753–6.PubMedCrossRefGoogle Scholar
  19. 19.
    Han YF, Zhao J, Ma LY, Yin JH, Chang WJ, Zhang HW, et al. Factors predicting occurrence and prognosis of hepatitis- B-virus-related hepatocellular carcinoma. World J Gastroenterol. 2011;17:4258–70.PubMedCrossRefGoogle Scholar
  20. 20.
    Smyth MJ, Cretney E, Kershaw MH, Hayakawa Y. Cytokines in cancer immunity and immunotherapy. Immunol Rev. 2004;202:275–93.PubMedCrossRefGoogle Scholar
  21. 21.
    Li N, Fu H, Tie Y, Hu Z, Kong W, Wu Y, et al. miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells. Cancer Lett. 2009;275:44–53.PubMedCrossRefGoogle Scholar
  22. 22.
    Sun B, Karin M. Inflammation and liver tumorigenesis. Front Med. 2013;7(2):242–54. doi: 10.1007/s11684-013-0256-4.Epub2013May17.PubMedCrossRefGoogle Scholar
  23. 23.
    Chen L, Zhang Q, Chang W, Du Y, Zhang H, Cao G. Viral and host inflammation-related factorsthat can predict the prognosis of hepatocellular carcinoma. Eur J Cancer. 2012;48:1977–87.PubMedCrossRefGoogle Scholar
  24. 24.
    Fan HB, Guo YB, Wang BJ, Zhu YF, Wu AH, Hou JL, et al. Expression of IFN-alpha/beta receptor in the PBMCs and liver of patients with hepatitis B and its clinical significance. Nan Fang Yi Ke Da Xue Xue Bao. 2008;28:979–81.PubMedGoogle Scholar
  25. 25.
    Liu AM, Yao TJ, Wang W, Wong KF, Lee NP, Fan ST, et al. Circulating miR-15b and miR-130b in serum as potential markers for detecting hepatocellular carcinoma: a retrospective cohort study. BMJ Open. 2012;2:e000825.PubMedCentralPubMedCrossRefGoogle Scholar
  26. 26.
    Zhao A, Zeng Q, Xie X, Zhou J, Yue W, Li Y, et al. MicroRNA-125b induces cancer cell apoptosis through suppression of Bcl-2 expression. J Genet Genomics. 2012;39:29–35.PubMedCrossRefGoogle Scholar
  27. 27.
    Wang WH, Studach LL, Andrisani OM. Proteins ZNF198 and SUZ12 are down-regulated in hepatitis B virus (HBV) X protein-mediated hepatocyte transformation and in HBV replication. Hepatology. 2011;53:1137–47.PubMedCentralPubMedCrossRefGoogle Scholar
  28. 28.
    Hu HM, Chen Y, Liu L, Zhang CG, Wang W, Gong K, et al. C1orf61 acts as a tumor activator in human hepatocellular carcinoma and is associated with tumorigenesis and metastasis. FASEB J. 2013;27:163–73.PubMedCrossRefGoogle Scholar
  29. 29.
    Sakai M, Shimokawa T, Kobayashi T, Matsushima S, Yamada Y, Nakamura Y, et al. Elevated expression of C10orf3 (chromosome 10 open reading frame 3) is involved in the growth of human colon tumor. Oncogene. 2006;25:480–6.PubMedGoogle Scholar
  30. 30.
    Jing Z, Yuan X, Zhang J, Huang X, Zhang Z, Liu J, et al. Chromosome 1 open reading frame 190 promotes activation of NF-κB canonical pathway and resistance of dendritic cells to tumor-associated inhibition in vitro. J Immunol. 2010;185:6719–27.PubMedCrossRefGoogle Scholar

Copyright information

© Federación de Sociedades Españolas de Oncología (FESEO) 2013

Authors and Affiliations

  • H. Li
    • 1
  • L. Sun
    • 2
  • X. Chen
    • 1
  • W. Xiong
    • 1
  • D. Hu
    • 1
  • S. Jie
    • 2
    Email author
  1. 1.Center for Stem Cell Research and Application, Union Hospital, Tongji Medical CollegeHuazhong University of Science and TechnologyWuhanPeople’s Republic of China
  2. 2.Department of Infectious Diseases, Union Hospital, Tongji Medical CollegeHuazhong University of Science and TechnologyWuhanPeople’s Republic of China

Personalised recommendations